For more information or confidential assistance
se habla español

Deceptive Marketing at Crux of Androgel Lawsuit

The U.S. Food and Drug Administration has yet to approve any type of testosterone replacement therapy as a treatment for age-associated low testosterone levels, otherwise known as “Low T.” Yet manufacturers of testosterone supplements have aggressively marketed products like Androgel to thousands of middle aged American men who believed they... Read more »

New Fresenius Dialysis Lawsuit Joins MDL 2428

Mason v. Fresenius Medical Care Holdings, Inc. was filed directly into multidistrict litigation (MDL 2428) on December 10, 2014, joining thousands of similar claims that allege Granuflo and Naturalyte dialysis additives are defective and unreasonably dangerous. Plaintiff Robert Mason brought his product liability complaint individually and on behalf of the... Read more »

FDA Panel Backs New Testosterone Drug Safety Limits

Amid concerns over testosterone therapy side effects, an FDA panel has backed limitations on labeling for testosterone to exclude prescriptions for men who take the therapy only to counteract ordinary signs of aging rather than specific hormonal abnormalities. The panel also voted overwhelmingly to require clinical safety trials for some... Read more »

Preliminary Discovery Plan Outlined for Low T Drug Lawsuits

Low T drug lawsuits alleging life-altering complications from Androgel, Testim and other testosterone supplements continue to mount in courtrooms across the nation. Plaintiffs claim they were inadequately warned about the risk of cardiovascular injury, stroke, heart attack and other severe health complications by the manufacturers of testosterone replacement products. A... Read more »